Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

AI投毒产业链的猖獗，本质上是人类旧有的流量投机思维在AI新大陆上的一次“赛博圈地”与暴力掠夺。从批量制造垃圾软文到复杂的代码级指令注入，投毒者试图用噪音淹没真相。然而，正如科技史上的每一次技术博弈，试图通过欺骗算法收割流量的行为，最终必然会被系统进 ...

VectorCertain Analyzed 3,434 OpenClaw Pull Requests Using Multi-Model Consensus, Identified Systemic Governance Failures, and Offered Creator Peter Steinberger a No-Cost SecureAgent License. He Joined ...